Edition:
India

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,742JPY
20 Jun 2019
Change (% chg)

¥9 (+0.52%)
Prev Close
¥1,733
Open
¥1,741
Day's High
¥1,762
Day's Low
¥1,737
Volume
971,800
Avg. Vol
1,334,436
52-wk High
¥1,988
52-wk Low
¥1,450

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 60,816.00 21.190
Dec 58,866.00 22.032
Sep 57,861.00 18.437
Jun 56,483.00 16.794
FY 2018 Mar '18 56,350.00 19.396
Dec 57,817.00 29.598
Sep 54,826.00 15.300
Jun 55,949.00 22.122
FY 2017 Mar '17 48,429.00 11.201
Dec 52,838.00 11.399
Sep 47,823.00 12.478
Jun 50,006.00 17.613
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 2 61,850.00 62,000.00 61,700.00 --
Quarter Ending Dec-19 2 63,300.00 64,400.00 62,200.00 --
Year Ending Mar-19 9 234,756.00 238,000.00 231,600.00 --
Year Ending Mar-20 10 247,185.00 253,000.00 240,300.00 246,400.00
Year Ending Mar-21 9 253,644.00 261,500.00 243,600.00 250,850.00
Earnings (per share)
Quarter Ending Sep-19 1 16.79 16.79 16.79 --
Quarter Ending Dec-19 1 19.29 19.29 19.29 --
Year Ending Mar-19 10 79.58 86.80 68.50 --
Year Ending Mar-20 11 77.89 98.30 55.62 84.24
Year Ending Mar-21 10 85.11 102.00 68.30 90.34
LT Growth Rate (%) 2 5.13 5.15 5.10 2.60
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 22.09 32.81 37.60
P/E High - Last 5 Yrs. 30.55 50.21 57.57
P/E Low - Last 5 Yrs. 13.18 27.54 28.56
Beta 0.75 0.97 0.96
Price to Sales (TTM) 2.96 9.66 11.36
Price to Book (MRQ) 2.38 3.93 4.55
Price to Tangible Book (MRQ) 4.34 4.22 5.38
Price to Cash Flow (TTM) 16.15 23.80 26.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 1.50 1.78 1.61
Dividend Yield - 5 Year Avg 1.48 1.47 1.35
Dividend 5 Year Growth Rate 5.39 6.37 6.48
Payout Ratio(TTM) 16.56 43.10 38.38

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.93 13.60 15.45
Sales (TTM) vs TTM 1 Yr. Ago 4.04 6.59 8.78
Sales - 5 Yr. Growth Rate 9.86 9.14 10.37
EPS (MRQ) vs Qtr. 1 Yr. Ago 9.25 18.37 18.98
EPS (TTM) vs TTM 1 Yr. Ago -9.21 -- --
EPS - 5 Yr. Growth Rate 10.49 5.51 7.13
Capital Spending - 5 Yr. Growth Rate 7.23 6.86 7.92

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.63 2.47 2.47
Current Ratio (MRQ) 3.21 3.46 3.43
LT Debt to Equity (MRQ) 8.09 13.22 14.15
Total Debt to Equity (MRQ) 12.25 18.33 19.83
Interest Coverage (TTM) -- 7.03 15.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 61.22 51.35 50.03
Gross Margin - 5 Yr. Avg. 62.44 50.42 51.25
EBITD Margin (TTM) 23.96 -- --
EBITD - 5 Yr. Avg 27.57 17.43 16.17
Operating Margin (TTM) 19.27 -6.04 -10.45
Operating Margin - 5 Yr. Avg. 22.84 13.66 11.40
Pre-Tax Margin (TTM) 18.42 -6.55 -10.93
Pre-Tax Margin - 5 Yr. Avg. 22.44 19.64 16.12
Net Profit Margin (TTM) 13.65 -10.21 -14.72
Net Profit Margin - 5 Yr. Avg. 16.38 14.75 11.30
Effective Tax Rate (TTM) 25.92 19.64 20.09
Effective Tax Rate - 5 Yr. Avg. 26.97 22.73 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 930,720,208 786,833,420
Net Income/Employee (TTM) -- 109,353,519 92,508,121
Receivable Turnover (TTM) 2.87 5.56 5.83
Inventory Turnover (TTM) 2.76 2.56 3.69
Asset Turnover (TTM) 0.60 0.85 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.19 10.06 9.69
Return on Assets - 5 Yr. Avg. 9.66 11.19 10.66
Return on Investment (TTM) 9.78 12.52 12.15
Return on Investment - 5 Yr. Avg. 11.69 14.23 13.56
Return on Equity (TTM) 11.08 13.83 17.02
Return on Equity - 5 Yr. Avg. 13.29 15.49 15.08
  1 Year 3 Year 5 Year
Sales % 4.04 6.22 9.86
EPS (TTM) % -9.23 -15.15 10.49
Dividend % 0.00 1.32 5.39
Note: Units in Millions of US Dollars

Performance for Santen Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.19 5.57 99 80
13 Week 5.67 9.69 99 24
26 Week -0.52 -0.46 99 31
52 Week -10.99 -0.19 99 69
YTD 9.27 4.97 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.66%
# of Holders: 255
Total Shares Held: 218,539,713
3 Mo. Net Change: 10,998,207
# New Positions: 6
# Closed Positions: 9
# Increased Positions: 62
# Reduced Positions: 65
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.